Categories AlphaGraphs, Earnings, Health Care
Vertex Pharmaceuticals (VRTX) reports Q1 2020 earnings results
Revised full-year product revenue guidance
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020.
On GAAP basis, first quarter EPS was $2.29 vs. $1.03 in the first quarter of 2019. Non-GAAP EPS was $2.56, compared to $1.14 in the first quarter of 2019.
Total revenues increased 76% to $1.51 billion.
You may also like:
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
